Annual EBITDA
$476.12 M
+$112.97 M+31.11%
December 31, 2024
Summary
- As of February 26, 2025, MEDP annual EBITDA is $476.12 million, with the most recent change of +$112.97 million (+31.11%) on December 31, 2024.
- During the last 3 years, MEDP annual EBITDA has risen by +$256.39 million (+116.68%).
- MEDP annual EBITDA is now at all-time high.
Performance
MEDP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$132.88 M
+$13.09 M+10.93%
December 31, 2024
Summary
- As of February 26, 2025, MEDP quarterly EBITDA is $132.88 million, with the most recent change of +$13.09 million (+10.93%) on December 31, 2024.
- Over the past year, MEDP quarterly EBITDA has increased by +$38.59 million (+40.93%).
- MEDP quarterly EBITDA is now at all-time high.
Performance
MEDP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$476.12 M
+$38.59 M+8.82%
December 31, 2024
Summary
- As of February 26, 2025, MEDP TTM EBITDA is $476.12 million, with the most recent change of +$38.59 million (+8.82%) on December 31, 2024.
- Over the past year, MEDP TTM EBITDA has increased by +$112.97 million (+31.11%).
- MEDP TTM EBITDA is now at all-time high.
Performance
MEDP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MEDP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +31.1% | +40.9% | +31.1% |
3 y3 years | +116.7% | +40.9% | +31.1% |
5 y5 years | +216.5% | +40.9% | +31.1% |
MEDP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +116.7% | at high | +128.8% | at high | +117.6% |
5 y | 5-year | at high | +216.5% | at high | +282.1% | at high | +216.5% |
alltime | all time | at high | +443.1% | at high | +1218.2% | at high | +4622.9% |
Medpace Holdings EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $476.12 M(+31.1%) | $132.88 M(+10.9%) | $476.12 M(+8.8%) |
Sep 2024 | - | $119.79 M(+6.6%) | $437.53 M(+6.8%) |
Jun 2024 | - | $112.39 M(+1.2%) | $409.52 M(+7.2%) |
Mar 2024 | - | $111.06 M(+17.8%) | $382.05 M(+5.2%) |
Dec 2023 | $363.15 M(+20.6%) | $94.29 M(+2.7%) | $363.15 M(+6.1%) |
Sep 2023 | - | $91.79 M(+8.1%) | $342.16 M(+0.7%) |
Jun 2023 | - | $84.91 M(-7.9%) | $339.64 M(+5.2%) |
Mar 2023 | - | $92.16 M(+25.7%) | $322.82 M(+7.6%) |
Dec 2022 | $301.04 M(+37.0%) | $73.30 M(-17.9%) | $299.97 M(+5.4%) |
Sep 2022 | - | $89.27 M(+31.1%) | $284.74 M(+11.4%) |
Jun 2022 | - | $68.09 M(-1.8%) | $255.58 M(+8.6%) |
Mar 2022 | - | $69.31 M(+19.4%) | $235.43 M(+7.6%) |
Dec 2021 | $219.73 M(+17.8%) | $58.07 M(-3.4%) | $218.81 M(-1.1%) |
Sep 2021 | - | $60.11 M(+25.4%) | $221.21 M(+4.1%) |
Jun 2021 | - | $47.94 M(-9.0%) | $212.47 M(+6.6%) |
Mar 2021 | - | $52.69 M(-12.9%) | $199.31 M(+6.8%) |
Dec 2020 | $186.57 M(+24.0%) | $60.47 M(+17.7%) | $186.57 M(+11.4%) |
Sep 2020 | - | $51.36 M(+47.7%) | $167.54 M(+10.8%) |
Jun 2020 | - | $34.78 M(-12.9%) | $151.22 M(-3.5%) |
Mar 2020 | - | $39.95 M(-3.6%) | $156.68 M(+4.1%) |
Dec 2019 | $150.45 M | $41.44 M(+18.2%) | $150.45 M(+1.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | $35.05 M(-12.9%) | $148.62 M(-1.4%) |
Jun 2019 | - | $40.24 M(+19.3%) | $150.71 M(+4.7%) |
Mar 2019 | - | $33.73 M(-14.8%) | $143.91 M(+2.9%) |
Dec 2018 | $139.85 M(+26.0%) | $39.61 M(+6.7%) | $139.85 M(+9.6%) |
Sep 2018 | - | $37.13 M(+11.0%) | $127.57 M(+7.0%) |
Jun 2018 | - | $33.44 M(+12.7%) | $119.22 M(+5.0%) |
Mar 2018 | - | $29.67 M(+8.6%) | $113.50 M(+2.3%) |
Dec 2017 | $110.98 M(+11.6%) | $27.32 M(-5.1%) | $110.98 M(+9.5%) |
Sep 2017 | - | $28.79 M(+3.9%) | $101.34 M(+2.0%) |
Jun 2017 | - | $27.72 M(+2.1%) | $99.38 M(-0.9%) |
Mar 2017 | - | $27.15 M(+53.5%) | $100.23 M(+0.8%) |
Dec 2016 | $99.45 M(+11.8%) | $17.69 M(-34.1%) | $99.45 M(+4.2%) |
Sep 2016 | - | $26.82 M(-6.1%) | $95.45 M(+2.4%) |
Jun 2016 | - | $28.57 M(+8.3%) | $93.26 M(+2.3%) |
Mar 2016 | - | $26.38 M(+92.7%) | $91.14 M(+2.5%) |
Dec 2015 | $88.95 M(+1.5%) | $13.69 M(-44.4%) | $88.95 M(+18.2%) |
Sep 2015 | - | $24.63 M(-6.9%) | $75.26 M(+48.6%) |
Jun 2015 | - | $26.44 M(+9.3%) | $50.63 M(+109.3%) |
Mar 2015 | - | $24.19 M(+139.9%) | $24.19 M(+139.9%) |
Mar 2014 | - | $10.08 M | $10.08 M |
Dec 2013 | $87.66 M | - | - |
FAQ
- What is Medpace Holdings annual EBITDA?
- What is the all time high annual EBITDA for Medpace Holdings?
- What is Medpace Holdings annual EBITDA year-on-year change?
- What is Medpace Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Medpace Holdings?
- What is Medpace Holdings quarterly EBITDA year-on-year change?
- What is Medpace Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Medpace Holdings?
- What is Medpace Holdings TTM EBITDA year-on-year change?
What is Medpace Holdings annual EBITDA?
The current annual EBITDA of MEDP is $476.12 M
What is the all time high annual EBITDA for Medpace Holdings?
Medpace Holdings all-time high annual EBITDA is $476.12 M
What is Medpace Holdings annual EBITDA year-on-year change?
Over the past year, MEDP annual EBITDA has changed by +$112.97 M (+31.11%)
What is Medpace Holdings quarterly EBITDA?
The current quarterly EBITDA of MEDP is $132.88 M
What is the all time high quarterly EBITDA for Medpace Holdings?
Medpace Holdings all-time high quarterly EBITDA is $132.88 M
What is Medpace Holdings quarterly EBITDA year-on-year change?
Over the past year, MEDP quarterly EBITDA has changed by +$38.59 M (+40.93%)
What is Medpace Holdings TTM EBITDA?
The current TTM EBITDA of MEDP is $476.12 M
What is the all time high TTM EBITDA for Medpace Holdings?
Medpace Holdings all-time high TTM EBITDA is $476.12 M
What is Medpace Holdings TTM EBITDA year-on-year change?
Over the past year, MEDP TTM EBITDA has changed by +$112.97 M (+31.11%)